GL1X · GenesisL1 explorer

MolNFT v1 · #131312 · protein

Ligand binding to farnesoid-X-receptor

5Q1F · Bile acid receptor: “Ligand binding to farnesoid-X-receptor”. X-ray diffraction, 1 ligand (9NJ), 5 pockets (best druggability 0.86). MolNFT v1 #131312 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5Q1F
Type
protein
Length
479 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bile acid receptor; Coactivator peptide src-1 HD3
UniProt
Q96RI1, A8K1V4
Ligands
9NJ
Pockets
5 · best druggability 0.86

Structure

x-ray diffraction · 4 distinct chains · 71% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABile acid receptorprotein22970% helix, 0% strandQ96RI1
BCoactivator peptide src-1 HD3protein1173% helix, 0% strandA8K1V4
CBile acid receptorprotein22972% helix, 0% strandQ96RI1
DCoactivator peptide src-1 HD3protein1080% helix, 0% strandA8K1V4

Ligands and binding sites

  • 9NJ · Trans-4-({(2S)-2-cyclohexyl-2-[2-(2,6-dimethoxypyridin-3-yl)-5-fluoro-1H-benzimidazol-1-yl]acetyl}amino) cyclohexane-1-carboxylic acid · ligand · 2 copies · chains A, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13880.860.94389NJ
25510.810.87619NJ
3940.370.7617empty
4960.370.7517empty
5500.310.7712empty

Interfaces

3 interfaces between chains.

  • C–D · 594 Ų buried · 7 hydrogen bonds · protein-protein
  • A–B · 574 Ų buried · 7 hydrogen bonds · protein-protein
  • A–C · 131 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 5Q1F · Ligand binding to FARNESOID-X-RECEPTOR · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.